Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit.
We aim to create futures for patients, their families and our employees.
Learn more about our mission, discover our “Whole You” benefits package and search for your next career opportunity: https://www.formatherapeutics.com/careers/
Read our community guidelines: https://www.formatherapeutics.com/community-guidelines/
Company Details
- Employees
- 208
- Founded
- -
- Address
- 300 N Beacon St,
- Phone
- 617-679-1970
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- formatherapeutics.com
- HQ
- Watertown, Massachusetts
Forma Therapeutics Questions
Forma Therapeutics's helpline number is 617-679-1970
Forma Therapeutics's website is formatherapeutics.com
Forma Therapeutics's LinkedIn profile is https://www.linkedin.com/company/forma-therapeutics
Forma Therapeutics has
208 employees.
View email and phone details for 208
employees at Forma Therapeutics.
Forma Therapeutics's industry is
Biotechnology Research
Forma Therapeutics's top competitors are
Kymera Therapeutics,
Sage Therapeutics,
Novo Nordisk,
Relay Therapeutics,
Ksq Therapeutics, Inc.,
Verve Therapeutics,
Magenta Therapeutics,
Akebia Therapeutics,
Beam Therapeutics,
Skyhawk Therapeutics.
Forma Therapeutics's support email address is info@formatherapeutics.com
Forma Therapeutics's categories are Biotechnology Research
Forma Therapeutics's founding year is 2007
